Rabbit anti-thymocyte globulin to prevent GVHD

被引：3
|
作者：
Rambaldi, Alessandro [1 ]
机构：
[1] Azienda Osped Papa Giovanni XXIII, Hematol & BMT Unit, I-24127 Bergamo, Italy
来源：
LANCET ONCOLOGY | 2016年 / 17卷 / 02期
关键词：
VERSUS-HOST-DISEASE; FREE SURVIVAL;
D O I：
10.1016/S1470-2045(15)00516-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [41] Tailored Rabbit Anti-Thymocyte Globulin Induction (rATG) Dosing for Kidney Transplantation.
    Singh, N.
    Rossi, A.
    Savic, M.
    Rubocki, R.
    Parker, M.
    Vella, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 386 - 386
  • [42] Rabbit anti-thymocyte globulin induces cell death in PBMNC subpopulations by secondary necrosis
    Grüllich, C
    Ziegler, C
    Finke, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S146 - S146
  • [43] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    TRANSPLANTATION, 2000, 69 (08) : S159 - S159
  • [44] Rabbit Anti-thymocyte Globulin Induction is Not Associated with Improved Outcomes in Liver Transplant Recipients
    Nguyen, P.
    Wilson, N.
    Saracino, G.
    Patel, R.
    Asrani, S. K.
    Testa, G.
    Sam, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 358 - 359
  • [45] Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
    Walter J. F. M. van der Velden
    Goda Choi
    Moniek A. de Witte
    Arnold van der Meer
    Anton F. J. de Haan
    Nicole M. A. Blijlevens
    Gerwin Huls
    Jürgen Kuball
    Suzanne van Dorp
    Bone Marrow Transplantation, 2021, 56 : 2651 - 2655
  • [46] Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
    van der Velden, Walter J. F. M.
    Choi, Goda
    de Witte, Moniek A.
    van der Meer, Arnold
    de Haan, Anton F. J.
    Blijlevens, Nicole M. A.
    Huls, Gerwin
    Kuball, Jurgen
    van Dorp, Suzanne
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2651 - 2655
  • [47] Low incidence of hyperacute graft-versus-host disease (GVHD) with effective GVHD prophylaxis based on anti-thymocyte globulin
    Radici, Vera
    Stocker, Nicolas
    Dulery, Remy
    Brissot, Eolia
    Bannet, Anne
    van de Wyngaert, Zoe
    Sestili, Simona
    Belhocine, Ramdane
    Bonin, Agnes
    Ledraa, Tounes
    Mohty, Mohamad
    Malard, Florent
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (05) : 630 - 633
  • [48] ANTI-THYMOCYTE GLOBULIN (ATG) IN HUMAN MARROW TRANSPLANTATION
    WEIDEN, PL
    DONEY, K
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1979, 7 : 102 - 102
  • [49] EFFECT OF ANTI-THYMOCYTE GLOBULIN ON ISLET OF LANGERHANS TRANSPLANTATION
    FRIEDMAN, EA
    BEYER, MM
    NEPHRON, 1978, 22 (1-3) : 212 - 216
  • [50] Administration of anti-thymocyte globulin: a comparison of two protocols
    A B Clemmons
    M E Hartranft
    V Kota
    J Pantin
    F T Awan
    H Salman
    A P Jillella
    Bone Marrow Transplantation, 2014, 49 : 1535 - 1537
12345